MENU
MIST
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Milestone Pharmaceuticals (MIST) Earnings Date & Reports

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines... Show more

A.I. Advisor
published Earnings

MIST is expected to report earnings to rise 48.33% to -17 cents per share on March 31

Milestone Pharmaceuticals MIST Stock Earnings Reports
Q4'25
Est.
$-0.18
Q3'25
Beat
by $0.04
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.11
Q4'24
Missed
by $0.03
The last earnings report on November 12 showed earnings per share of -11 cents, beating the estimate of -15 cents. With 1.15M shares outstanding, the current market capitalization sits at 161.06M.
View a ticker or compare two or three
MIST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MIST showed earnings on November 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer and manufacturer of cardiovascular medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1111 Dr. Frederik-Philips Boulevard
Phone
+1 514 336-0444
Employees
47
Web
https://www.milestonepharma.com